Systematic Data Mining Reveals Synergistic H3R/MCHR1 Ligands.

Area of Science:

• Pharmacology
• Drug Discovery
• Computational Chemistry

Background:

• Obesity treatment requires identifying effective drug targets and synergistic compound actions.
• Existing methods may not fully capture off-target effects or synergistic mechanisms.

Purpose of the Study:

• To develop a ligand-centric data mining approach for identifying synergistic target pairs for obesity treatment.
• To exclude compounds with detrimental off-target effects.
• To discover novel therapeutic strategies for obesity.

Main Methods:

• Utilized a ligand-centric data mining strategy comparing ligands with known activities against obesity targets.
• Employed fingerprint representations for compound comparison.
• Evaluated mechanisms of action for compounds exhibiting activity against multiple targets.
• Performed in vitro validation of computational predictions.

Main Results:

• Identified target pairs with potential for synergistic positive effects in obesity treatment.
• Excluded compounds with known detrimental off-target activities.
• Discovered that three known melanin-concentrating hormone receptor 1 (MCHR1) modulators possess previously unrecognized submicromolar affinity for the histamine H3 receptor (H3R).

Conclusions:

• The developed ligand-centric data mining approach effectively identifies potential synergistic drug targets for obesity.
• The dual activity of MCHR1 modulators on H3R represents a novel synergistic mechanism.
• This finding suggests a new therapeutic avenue for obesity management by targeting both MCHR1 and H3R.